Methoxy PEG Dimyristoyl-rac-glycero-·Ç·²¹ú¼Ê,Ö§Á´¾ÛÒÒ¶þ´¼ÑÜÉúÎï,Ö±Á´¾ÛÒÒ¶þ´¼ÑÜÉúÎï"> Methoxy PEG Dimyristoyl-rac-glycero Methoxy PEG Dimyristoyl-rac-glycero, MW 2000"> ·Ç·²¹ú¼Ê,Ö§Á´¾ÛÒÒ¶þ´¼ÑÜÉúÎï,Ö±Á´¾ÛÒÒ¶þ´¼ÑÜÉúÎï"> Methoxy PEG Dimyristoyl-rac-glycero-·Ç·²¹ú¼Ê,Ö§Á´¾ÛÒÒ¶þ´¼ÑÜÉúÎï,Ö±Á´¾ÛÒÒ¶þ´¼ÑÜÉúÎï"> Methoxy PEG Dimyristoyl-rac-glycero Methoxy PEG Dimyristoyl-rac-glycero, MW 2000">

·Ç·²¹ú¼Ê

²úÆ·ÖÐÐÄ

ÁªÏµ·Ç·²¹ú¼Ê

+86-010-82156767

ÏúÊÛרÓãº

+86-010-62983737 

+86-15522507305 

+86-15522507319 

+86-15522507326

µØÖ·£º±±¾©Êк£µíÇøÎ÷С¿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã

undefined
+
  • undefined

Methoxy PEG Dimyristoyl-rac-glycero

²úÆ·´úºÅ£º

M-DMG-2000

²úÆ·´¿¶È£º

¡Ý 95%£¬£¬£¬£¬£¬£¬ £¬£¬¡Ý 99% ¿Éƾ֤¿Í»§ÐèÇóÌṩ²î±ð´¿¶ÈµÄ²úÆ·

°ü×°¹æ¸ñ£º

1g, 10g, 100gµÈ

·Ö×ÓÁ¿£º

2494¡À200 DaµÈ

ËùÊô·ÖÀࣺ

²úÆ·×Éѯ£º

¿ÆÑпͻ§Ð¡ÅúÁ¿Ò»¼ü²É¹ºµØÖ·£¨Ð¡ÓÚ5¿Ë£©

  • ²úÆ·ÐÎò
  • ²Î¿¼ÎÄÏ×
  •        ·Ç·²¹ú¼Ê¿Æ¼¼Éú²úµÄ M-DMG-2000 ÓÚ2021Äê9ÔÂ16ÈÕÔÚ¹ú¼ÒÒ©Æ·¼àÊÓ¹ÜÀí¾ÖÒ©Æ·ÉóÆÀÖÐÐÄ»ñµÃÒ©Óø¨ÁϹҺţ¬£¬£¬£¬£¬£¬ £¬£¬¹ÒºÅºÅ£º20210000376¡£¡£¡£¡£¡£ ¡£

    ²úÆ·±àÂë

    ²úÆ·´úºÅ

    A3294

    M-DMG-2000

           ÄÉÃ׿ÅÁ£Ö¬ÖÊÌå(Lipid nanoparticles£¬£¬£¬£¬£¬£¬ £¬£¬LNPs)¼´LNPs µÝËÍϵͳ£¬£¬£¬£¬£¬£¬ £¬£¬Òµ½çͨ³£ÒÔΪͨ¹ý·Ç¹²¼ÛÇ׺ÍÁ¦ºÍϸ°ûĤÍŽᲢͨ¹ýÄÚÍÌ×÷Óñ»ÉãÈ¡£¡£¡£¡£¡£ ¡£¬£¬£¬£¬£¬£¬ £¬£¬½øÈëϸ°ûºó mRNA ÌÓÀëÄÚÍÌСÅÝ£¬£¬£¬£¬£¬£¬ £¬£¬±»Êͷŵ½Ï¸°ûÖÊÖбí´ï°ÐÂѰס£¡£¡£¡£¡£ ¡£

    ¡¡¡¡LNPsÓë¹Å°åÖ¬ÖÊÌå×î´óµÄ²î±ðÊÇËüÃÇÔÚÁ£×Ó½¹µãÄÚÐγɽºÊø½á¹¹£¬£¬£¬£¬£¬£¬ £¬£¬ÆäÐÎ̬¿ÉÒÔÆ¾Ö¤Åä·½ºÍºÏ³É²ÎÊý¸Ä±ä¡£¡£¡£¡£¡£ ¡£LNPsͨ³£ÓÉËÄÖÖÖ÷ÒªÒòËØ×é³É£ºÑôÀë×Ó»ò¿ÉµçÀëµÄÖ¬ÖÊ(Óë´ø¸ºµçºÉµÄÒÅ´«ÎïÖʸ´ºÏ£¬£¬£¬£¬£¬£¬ £¬£¬ÓÐÖúÓÚÄÚÔÚÌåÌÓÒÝ)¡¢Á×Ö¬(¿ÅÁ£½á¹¹)¡¢µ¨¹Ì´¼(ÓÐÖúÓÚÎȹÌÐÔºÍĤÈÚºÏ)¡¢¾ÛÒÒ¶þ´¼Ö¬ÖÊ(Ìá¸ßÎȹÌÐÔºÍÑ­»·)¡£¡£¡£¡£¡£ ¡£LNPsºËËáת´ïµÄÓÐÓÃÐÔÒÔ¼°Æä¼òÆÓµÄºÏ³É¡¢Ð¡Ìå»ýºÍѪÇåÎȹÌÐÔʹÆäÔÚ¸öÐÔ»¯»ùÒòÖÎÁÆÓ¦ÓÃÖÐÓÈΪÖ÷Òª¡£¡£¡£¡£¡£ ¡£

    ¡¡¡¡ÏÖÔÚ£¬£¬£¬£¬£¬£¬ £¬£¬Moderna¡¢CureVac¡¢BioNTech£¬£¬£¬£¬£¬£¬ £¬£¬¾ù½ÓÄÉÖ¬ÖÊÄÉÃ×ÊÖÒÕµÝËÍ(LNP)£¬£¬£¬£¬£¬£¬ £¬£¬ÕâÒ²Êǵ±ÏÂÔÚºËËáÒ©ÎïÁìÓòÓ¦ÓýÏÁ¿ÆÕ±éµÄµÝËÍÊÖÒÕÀàÐÍ¡£¡£¡£¡£¡£ ¡£

    ¡¡¡¡·Ç·²¹ú¼Ê¿Æ¼¼¿ÉÌṩLNPsµÝËÍϵͳ¸¨ÁϵÄʵÑéÊÒÓëGMP¼¶±ð²úÆ·¡£¡£¡£¡£¡£ ¡£¹«Ë¾³Ð¼Ì¡°ÒÔÖÊÁÏÁ¢ÒìÒýÁìÉúÎïÒ½Ò©Á¢Ò족µÄ×ÚÖ¼£¬£¬£¬£¬£¬£¬ £¬£¬×¢ÖØÊÖÒÕÑз¢£¬£¬£¬£¬£¬£¬ £¬£¬ÈçÄúÐèÒªÆäËüδÁгöµÄ½á¹¹£¬£¬£¬£¬£¬£¬ £¬£¬»¶Ó­ÄúÀ´µç×Éѯ£¬£¬£¬£¬£¬£¬ £¬£¬·Ç·²¹ú¼Ê¿Æ¼¼»áΪÄúÌṩ¶¨ÖƺϳɷþÎñ£¬£¬£¬£¬£¬£¬ £¬£¬ÎªÄúµÄÑз¢ÏîÄ¿Ìṩȫ·½Î»Ö§³Ö·þÎñ¡£¡£¡£¡£¡£ ¡£

    ¡¡¡¡·Ç·²¹ú¼Ê¿Æ¼¼Ìṩ¶àÖÖ°ü×°¹æ¸ñ£¬£¬£¬£¬£¬£¬ £¬£¬ÈôÊÇÄúÐèÒª¸üС°ü×°»ò·ÖװΪÆäËû¹æ¸ñÇëÓëÎÒÃÇÁªÏµ¡£¡£¡£¡£¡£ ¡£

    ¡¡¡¡·Ç·²¹ú¼Ê¿Æ¼¼Í¬Ê±ÌṩÆäËû·Ö×ÓÁ¿µÄM-DMGÑÜÉúÎï²úÆ·¡¢´óÅúÁ¿Éú²ú²úÆ·¼°GMP¼¶±ð²úÆ·£¬£¬£¬£¬£¬£¬ £¬£¬ÈçÄãÐèÒªÇëÓëÎÒ˾sales@jenkem.comÁªÏµ¡£¡£¡£¡£¡£ ¡£

            ´Ë²úÆ·ÊÇÌØ¶¨ºÏ³É²úÆ·£¬£¬£¬£¬£¬£¬ £¬£¬ÈçÐè×Éѯ²É¹º£¬£¬£¬£¬£¬£¬ £¬£¬ÇëÓë·Ç·²¹ú¼Ê¿Æ¼¼ÏúÊÛÈ¡µÃÁªÏµ¡£¡£¡£¡£¡£ ¡£

  • 1.Gu, T., et al., Intratumoural delivery of TRAIL mRNA induces colon cancer cell apoptosis, Biomedicine & Pharmacotherapy, 2024, V. 174. Keywords: mRNA; Lipid nanoparticles; apoptosis; death receptors; TRAIL; SM-102; DMG-PEG2000

    2. Zhijie LiangZ., et al., Galactose receptor-mediated hepatic targeting system: engineering of quinary cationic liposomes for resveratrol delivery against hepatic steatosis, RSC Advances, 15 (25), 2025

²úƷѯ¼Û

ÍøÕ¾µØÍ¼